BIO-TECHNE Corp (NASDAQ:TECH) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 04, 2026. The Healthcare company reported Q0 revenue…
BIO-TECHNE Corp (NASDAQ:TECH) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 04, 2026.
The Healthcare company reported Q0 revenue of .
BIO-TECHNE Corp's stock currently trades at $68.67 with a market capitalization of $9.4B.
Current market data
NASDAQ · TECH
$72.22
Down: -$0.17 · -0.23%
Live quote updated
Keep reading
earnings ·
analyst ·
analyst ·
analyst ·
